Bioretec (OHEL:BRETEC) FCF Margin %: -432.60% (As of Dec. 2025)


What is Bioretec FCF Margin %?

Bioretec OHEL:BRETEC +7.48% FCF Margin % is -432.60% as of Dec. 2025. The stock has 5 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Bioretec ranks worse than 90.34% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bioretec's Free Cash Flow for the six months ended in Dec. 2025 was €-6.26 Mil. Bioretec's Revenue for the six months ended in Dec. 2025 was €1.45 Mil. Therefore, Bioretec's FCF Margin % for the quarter that ended in Dec. 2025 was -432.60%.

As of today, Bioretec's current FCF Yield % is -33.52%.

The historical rank and industry rank for Bioretec's FCF Margin % or its related term are showing as below:

OHEL:BRETEC' s FCF Margin % Range Over the Past 10 Years
Min: -294.76   Med: -112.77   Max: -69.72
Current: -294.76

During the past 8 years, the highest FCF Margin % of Bioretec was -69.72%. The lowest was -294.76%. And the median was -112.77%.

OHEL:BRETEC's FCF Margin % is ranked worse than
90.34% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: -0.375 vs OHEL:BRETEC: -294.76

Bioretec FCF Margin % Related Terms

Bioretec FCF Margin % Historical Data

* Premium members only.

The historical data trend for Bioretec's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioretec FCF Margin % Chart

Bioretec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -138.79 -89.06 -92.11 -128.43 -293.75

Bioretec Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -115.77 -131.78 -125.71 -197.96 -432.60

OHEL:BRETEC vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Bioretec's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioretec FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioretec's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bioretec's FCF Margin % falls into.


Bioretec FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bioretec's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-10.346/3.522
=-293.75 %

Bioretec's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-6.264/1.448
=-432.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -432.60% mean?
Bioretec (OHEL:BRETEC) has a FCF Margin % of -432.60% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioretec and its competitors. According to the industry distribution chart, Bioretec ranks #739 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 90.3%.
Is Bioretec's FCF Margin % too high?
Bioretec's current FCF Margin % is -432.60%. Based on the distribution chart, Bioretec ranks #739 out of 818 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Bioretec's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bioretec ranks #739 out of 818 companies for FCF Margin %. This places Bioretec in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioretec and its competitors. Bioretec's current FCF Margin % is -432.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioretec stock overvalued right now?
Based on GuruFocus' analysis, Bioretec (OHEL:BRETEC) is currently considered Possible Value Trap. The stock's GF Value™ is €0.19, compared to a current price of €0.02 — trading 87.9% below its estimated fair value. The current FCF Margin % is -432.60%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bioretec (OHEL:BRETEC), the current FCF Margin % is -432.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioretec Business Description

Other Exchanges 0TN:Germany
Address Yrittajankulma 5, Tampere, FIN, 33710
Bioretec Ltd is a medical device company focusing on the development of bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. It has developed the following product lines: RemeOs and Activa. RemeOs is based on a high-performance magnesium alloy and hybrid composite, introducing absorbable materials for enhanced surgical outcomes. The RemeOs implants (RemeOs Screw Lag, RemeOs Screw Lag Solid, RemeOs Screw FT, etc.) are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The Activa implants (ActivaPin, ActivaNail, ActivaScrew, etc.) are based on fully absorbable biopolymer products that facilitate natural bone healing without requiring removal surgery.